Subscribe To
Uipath (path) gains but lags market: what you should know
Uipath (PATH) closed at $32.40 in the latest trading session, marking a +0.97% move from the prior day....
February 24, 2022, 7:15 pm
Uipath (path) gains but lags market: what you should know
Uipath (PATH) closed at $32.40 in the latest trading session, marking a +0.97% move from the prior day....
February 24, 2022, 7:15 pm
Uipath: automation tech company, 58% growth, 10% net cash
UiPath: Automation Tech Company, 58% Growth, 10% Net Cash...
February 24, 2022, 4:29 pm
Uipath: automation tech company, 58% growth, 10% net cash
UiPath: Automation Tech Company, 58% Growth, 10% Net Cash...
February 24, 2022, 4:29 pm
Uipath: automation tech company, 58% growth, 10% net cash
UiPath: Automation Tech Company, 58% Growth, 10% Net Cash...
February 24, 2022, 4:29 pm
What's going on with baidu and pinduoduo shares today?
Shares of several Chinese companies, including Baidu Inc (NASDAQ: BIDU) and Pinduoduo Inc - ADR (NASDAQ: PDD), are trading lower following the Russian...
February 24, 2022, 3:12 pm
What's going on with baidu and pinduoduo shares today?
Shares of several Chinese companies, including Baidu Inc (NASDAQ: BIDU) and Pinduoduo Inc - ADR (NASDAQ: PDD), are trading lower following the Russian...
February 24, 2022, 3:12 pm
What's going on with baidu and pinduoduo shares today?
Shares of several Chinese companies, including Baidu Inc (NASDAQ: BIDU) and Pinduoduo Inc - ADR (NASDAQ: PDD), are trading lower following the Russian...
February 24, 2022, 3:12 pm
Compass pathways plc (cmps) ceo george goldsmith on q4 2021 results - earnings call transcript
COMPASS Pathways plc (CMPS) CEO George Goldsmith on Q4 2021 Results - Earnings Call Transcript...
February 24, 2022, 11:13 am
Compass pathways plc (cmps) ceo george goldsmith on q4 2021 results - earnings call transcript
COMPASS Pathways plc (CMPS) CEO George Goldsmith on Q4 2021 Results - Earnings Call Transcript...
February 24, 2022, 11:13 am
Compass pathways plc (cmps) ceo george goldsmith on q4 2021 results - earnings call transcript
COMPASS Pathways plc (CMPS) CEO George Goldsmith on Q4 2021 Results - Earnings Call Transcript...
February 24, 2022, 11:13 am
Gold's path to $2k: fed rate hikes won't hurt gold price rally this year, says wells fargo
(Kitco News) - The gold's bull market won't be stopped by the slate of upcoming Federal Reserve rate hikes expected to begin in March, according to We...
February 23, 2022, 5:08 pm
Gold's path to $2k: fed rate hikes won't hurt gold price rally this year, says wells fargo
(Kitco News) - The gold's bull market won't be stopped by the slate of upcoming Federal Reserve rate hikes expected to begin in March, according to We...
February 23, 2022, 5:08 pm
Gold's path to $2k: fed rate hikes won't hurt gold price rally this year, says wells fargo
(Kitco News) - The gold's bull market won't be stopped by the slate of upcoming Federal Reserve rate hikes expected to begin in March, according to We...
February 23, 2022, 5:08 pm
The ratings game: intel is on a ‘long and expensive' road but stock may not ‘meaningfully underperform further,' analyst says
Intel Corp. is on a “long and expensive” path as it tries to recapture its former glory, but its st...
February 23, 2022, 11:40 am
The ratings game: intel is on a ‘long and expensive' road but stock may not ‘meaningfully underperform further,' analyst says
Intel Corp. is on a “long and expensive” path as it tries to recapture its former glory, but its st...
February 23, 2022, 11:40 am
The ratings game: intel is on a ‘long and expensive' road but stock may not ‘meaningfully underperform further,' analyst says
Intel Corp. is on a “long and expensive” path as it tries to recapture its former glory, but its st...
February 23, 2022, 11:40 am
Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain
OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. The key claim in the application covered the drug...
February 23, 2022, 2:30 am
Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain
OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. The key claim in the application covered the drug...
February 23, 2022, 2:30 am
Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain
OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. The key claim in the application covered the drug...
February 23, 2022, 2:30 am